Notable Upgrades: GlaxoSmithKline plc (GSK), Hologic, Inc. (HOLX), Apple (AAPL)

Drug maker GlaxoSmithKline plc (GSK) had its rating upgraded to ‘Buy’ from ‘Neutral’ by analysts at Goldman Sachs (GS) on Monday.

GSK shares recently gained $0.20 to $47.58. In the past 52 weeks, shares of Brentford, the United Kingdom-based pharmaceutical company have traded between a low of $46.01 and a high of $56.73. Shares are down 5.82% year-over-year and 10.82% year-to-date.

The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.

Hologic, Inc. (HOLX) was raised to ‘Overweight’ from ‘Neutral’ and it was given a $32 from $28 price target at Piper Jaffray on Monday. The prior close was $24.14. The firm’s new PT represents expected upside of 32.56% from the stock’s current price-per-share

Hologic Inc. is priced at 16.14x next year’s forecasted earnings. Ticker has a PEG and price-to-sales ratio of 2.15 and 2.71, respectively. EPS is ($4.22). Currently, HOLX has a median Wall Street price target of $28.00 with a high target of $31.00.

In the past 52 weeks, shares of Bedford, Massachusett-based company have traded between a low of $19.25 and a high of $26.75 and are now at $24.65. Shares are up 22.82% year-over-year and 10.78% year-to-date.

The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.

Apple (AAPL) was given a $130 from $115 price target at Global Equities Research on Monday. The firm’s new PT implies 28.81% expected return from ticker’s current $100.92 pps.

Separately, Piper Jaffray analysts said in a research report this morning they believe Apple’s revenue could top expectations by 9% and its EPS by nearly 12% in the December quarter. The asset management firm kept an ‘Overweight’ rating on the stock with a $120 price target.

Apple Inc. shares are currently priced at 16.96x this year’s forecasted earnings compared to the industry’s 23.64x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.31 and 14.15, respectively. Price/Sales for the same period is 3.39 while EPS is $5.96. Currently, AAPL has a median Wall Street price target of $110.00 with a high target of $139.00.

In the past 52 weeks, shares of Cupertino, California-based company have traded between a low of $67.77 and a high of $103.74. Shares are up 51.76% year-over-year and 26.42% year-to-date.

The chart below shows where the equity has traded over the last year, with the 50-day and 200-day moving averages included.

Be the first to comment

Leave a Reply

Your email address will not be published.


*